These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9400627)

  • 1. Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection.
    Rich KC; Brambilla D; Pitt J; Moye J; Cooper E; Hillyer G; Mendez H; Fowler MG; Landay A
    Clin Immunol Immunopathol; 1997 Dec; 85(3):273-81. PubMed ID: 9400627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.
    Lambert JS; Moye J; Plaeger SF; Stiehm ER; Bethel J; Mofenson LM; Mathieson B; Kagan J; Rosenblatt H; Paxton H; Suter H; Landay A
    Clin Diagn Lab Immunol; 2005 May; 12(5):622-31. PubMed ID: 15879023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping.
    Plaeger-Marshall S; Isacescu V; O'Rourke S; Bertolli J; Bryson YJ; Stiehm ER
    Clin Immunol Immunopathol; 1994 Apr; 71(1):19-26. PubMed ID: 7511081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of lymphocyte activation in neonates infected with human immunodeficiency virus.
    Gallagher K; Gorre M; Harawa N; Dillon M; Wafer D; Stiehm ER; Bryson Y; Song D; Dickover R; Plaeger S
    Clin Diagn Lab Immunol; 1997 Nov; 4(6):742-7. PubMed ID: 9384301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells.
    Ríos Z; Ríos EO; Garcia MI; De Leon C; Guzman LM; Rodriguez W; Romero D; Hunter R
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S93-101. PubMed ID: 8574153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study.
    Pitt J; Brambilla D; Reichelderfer P; Landay A; McIntosh K; Burns D; Hillyer GV; Mendez H; Fowler MG
    J Infect Dis; 1997 Mar; 175(3):567-75. PubMed ID: 9041327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants.
    Le Chenadec J; Mayaux MJ; Guihenneuc-Jouyaux C; Blanche S;
    AIDS; 2003 Sep; 17(14):2053-61. PubMed ID: 14502008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers.
    Rich KC; Siegel JN; Jennings C; Rydman RJ; Landay AL
    Clin Diagn Lab Immunol; 1997 May; 4(3):358-61. PubMed ID: 9144377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR; Cone RW; Huber W; Battegay M; Vernazza PL; Weber R; Grob PJ; Opravil M
    AIDS; 1998 Nov; 12(16):2115-23. PubMed ID: 9833852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults.
    Ibegbu C; Spira TJ; Nesheim S; Mendez H; Lee F; Polliotti B; Caba J; Nahmias A
    Clin Immunol Immunopathol; 1994 Apr; 71(1):27-32. PubMed ID: 7511082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated CD8+DR+ lymphocytes in HIV-exposed infants with early positive HIV cultures: a possible early marker of intrauterine transmission. Women and Infants Transmission Study Group.
    Rich KC; Chang BH; Mofenson L; Fowler MG; Cooper E; Pitt J; Hillyer GV; Mendez H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):204-10. PubMed ID: 9257655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels.
    Di Paolo S; Schena A; Morrone LF; Manfredi G; Stallone G; Derosa C; Procino A; Schena FP
    Transplantation; 2000 May; 69(10):2049-54. PubMed ID: 10852595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of blood CD16/CD56 (NK) and HLA-DR/CD3-positive lymphocyte amounts in HIV-infected children, as related to clinical progression and p24-antigen/p24-antibody presence.
    Voiculescu C; Avramescu C; Balasoiu M; Turculeanu A; Radu E
    FEMS Immunol Med Microbiol; 1994 Sep; 9(3):217-21. PubMed ID: 7529081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME; Shearer WT; Kozinetz CA; Lewis DE
    J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy.
    Paul ME; Mao C; Charurat M; Serchuck L; Foca M; Hayani K; Handelsman EL; Diaz C; McIntosh K; Shearer WT;
    J Allergy Clin Immunol; 2005 Apr; 115(4):848-55. PubMed ID: 15806009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy.
    Bouscarat F; Levacher M; Landman R; Muffat-Joly M; Girard PM; Saimot AG; Brun-Vézinet F; Sinet M
    AIDS; 1998 Jul; 12(11):1267-73. PubMed ID: 9708405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.